Improvement of Renal Function with Selective Thromboxane Antagonism in Lupus Nephritis
- 16 February 1989
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 320 (7), 421-425
- https://doi.org/10.1056/nejm198902163200703
Abstract
To test the hypothesis that the vasoconstrictor thromboxane A2 may affect renal hemodynamics in lupus nephritis, we examined the short-term effects of a selective thromboxane-receptor antagonist, BM 13,177, and of low-dose aspirin.Keywords
This publication has 16 references indexed in Scilit:
- The clinical significance of inhibition of renal prostaglandin synthesisKidney International, 1987
- Estimated rate of thromboxane secretion into the circulation of normal humans.Journal of Clinical Investigation, 1986
- Increased renal thromboxane production in murine lupus nephritis.Journal of Clinical Investigation, 1986
- Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus.Journal of Clinical Investigation, 1985
- Membranoproliferative GlomerulonephritisNew England Journal of Medicine, 1984
- Effects of Sulindac and Ibuprofen in Patients with Chronic Glomerular DiseaseNew England Journal of Medicine, 1984
- The 1982 revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1982
- Selective Cumulative Inhibition of Platelet Thromboxane Production by Low-dose Aspirin in Healthy SubjectsJournal of Clinical Investigation, 1982
- Low dose aspirin and inhibition of thromboxane B2 production in healthy subjectsThrombosis Research, 1980
- Aspirin-Induced Depression of Renal FunctionNew England Journal of Medicine, 1977